Patients’ perspective on allergen immunotherapy for respiratory allergy

The patient's perspective is crucial in AIT, as it directly impacts adherence and treatment outcomes. Allergic rhinitis and asthma significantly reduce the QoL, especially when poorly controlled, but their burdens are often underestimated. Adherence to AIT depends on multiple factors including age, physician engagement, perceived efficacy, convenience, education, and socioeconomic status. Effective communication, shared decision-making, and tailored education enhance long-term compliance, while financial barriers and lack of reimbursement remain significant obstacles. Patient-reported outcome measures (PROMs) are essential tools for assessing symptom burden, disease control, and QoL, supporting clinical decisions and research. Validated PROMs, as well as combined symptom-medication scores, help personalize care and are increasingly integrated into digital platforms for real-time monitoring. Respiratory patient associations play a vital role in promoting education, empowerment, and advocacy, enhancing adherence and access to care.